Clinical Trial Update: TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TachoSil to Surgicel Original for secondary control of local bleeding during hepatic resection in adults and children; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage

Drugs mentioned

• Surgicel Original (oxidized regenerated cellulose hemostat)
• TachoSil (fibrin sealant patch)

Snippet

Sponsor: Takeda | Conditions: Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2015-11-25